it will probably be cheaper to get approval in Europe than going for rosacea or MRSA to gain more revenue but I'm here for the long term so as long as they are still moving forward I'm happy
Ann: March 2023 Quarterly Activities Report and Appendix 4C, page-33
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
-0.013(3.73%) |
Mkt cap ! $586.1M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.8¢ | 31.5¢ | $1.580M | 4.851M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 425005 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 249445 | 26 |
View Market Depth
| Last trade - 14.39pm 12/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |